Brief: Bridgebio Pharma Reports Inducement Grants Under Nasdaq Listing Rule
11/08/2026 21:48
BRIEF-Bridgebio Pharma Reports Inducement Grants Under Nasdaq Listing Rule Aug 11 (Reuters) - BridgeBio Pharma, Inc. BBIO.O:
BRIDGEBIO PHARMA REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)
Source text: ID:nGNX3PXsFW
Further company coverage: BBIO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on BridgeBio Pharma
See all newsU.S. STOCKS ON THE MOVE-Becton Dickinson, Constellation Energy, Marvell
U.S. STOCKS ON THE MOVE-Constellation Energy, AMD
BridgeBio rises on FDA priority review for dwarfism drug
Brief: Bridgebio Announces FDA Acceptance And Priority Review Of NDA For Oral Infigratinib For Children With Achondroplasia
Brief: Bbp-418 Demonstrates Potential To Be Disease Modifying Therapy, Restoring Cardiac And Disease Markers To Unaffected Levels